Skip to NavigationSkip to content

News

A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research primarily pointed...
GSK appointment signals a return to oncology, Boehringer secures EU approval for Humira biosimilar, and we speak to some of the key candidates in the...
The FDA has expanded the use of Pfizer's Sutent to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma...
Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and with the FDA’s approval of...
Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own promise to make available a generic...
A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with peripheral artery disease, a...
A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to mask symptoms of opioid withdrawal,...
The EMA has awarded European marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta for the...
NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of Pfizer’s Ibrance and Novartis’ Kisqali.
Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. Two years later and the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches